#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2430	774.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1883	1883	T	1000	T,C,A,G	995,2,1,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2430	774.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1617	1617	C	998	C,G,T	996,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4157	794.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1966	1966	A	1078	A,G	1076,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4157	794.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2600	2600	C	956	C,T,A	953,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4157	794.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2674	2674	A	880	A,G,C	878,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4157	794.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3226	3226	C	962	C,A	961,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	G5V	NONSYN	13	15	GGT	529	531	GTT	138;139;140	G;T,G;T,C	138;138,1;139,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	E12K	NONSYN	34	36	GAA	550	552	AAA	155;155;157	A,C;A;A,T	154,1;154;155,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	F31L	NONSYN	91	93	TTT	607	609	TTG	197;197;195	T;T,A;G	197;196,1;195	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	640	642	CAA	214;213;212	C;A;A	214;213;212	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	S75P	NONSYN	223	225	TCC	739	741	CCT	193;191;193	C;C;T	193;191;193	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	V87A	NONSYN	259	261	GTA	775	777	GCA	171;169;167	G;C;A	171;169;167	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	V130L	NONSYN	388	390	GTC	904	906	CTC	211;212;213	C,A;T;C,A	210,1;212;212,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	R135C	NONSYN	403	405	CGC	919	921	TGT	224;227;228	T,C;G;T,C	222,2;227;227,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	T137A	NONSYN	409	411	ACG	925	927	GCG	226;227;226	G,C;C;G	225,1;227;226	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	E151K	NONSYN	451	453	GAA	967	969	AAG	216;218;218	A;A;G	216;218;218	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	970	972	AAT	223;225;225	A,G;A;T	222,1;225;225	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1168	1170	TTG	136;135;134	T;T,A;G	136;134,1;134	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1198	1200	AGC	126;127;127	A;G;C	125;126;126	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1267	1269	CTG	129;127;126	C,T;T,C;G	128,1;126,1;126	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1273	1275	TCC	117;116;116	T;C,T,A;C	117;114,1,1;116	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1288	1290	GTG	128;128;130	G;T;G	128;128;130	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1726	folP	852	852	93.78	folP.l15.c4.ctg.1	1958	109.9	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1339	1341	GCG	144;142;139	G,C;C,T;G	143,1;141,1;139	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5364	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3863	173.1	1	SNP	p	S91F	0	.	.	271	273	TCC	832	834	TCC	192;193;194	T,G;C;C	191,1;193;194	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5364	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3863	173.1	1	SNP	p	D95N	0	.	.	283	285	GAC	844	846	GAC	206;205;204	G;A;C	206;205;204	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5364	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3863	173.1	1	SNP	p	D95G	0	.	.	283	285	GAC	844	846	GAC	206;205;204	G;A;C	206;205;204	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	2020	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1841	137.1	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	997	997	T	250	T	250	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1150	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1649	86.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1727	1729	ATC	249;249;249	A;T,G,A;C,G,A	249;247,1,1;247,1,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1880	1882	GCA	236;236;239	G,T;C;A	235,1;236;239	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	1	SNP	p	D86N	0	.	.	256	258	GAC	833	835	GAC	248;247;245	G,C;A;C	247,1;247;245	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	1	SNP	p	S87R	0	.	.	259	261	AGT	836	838	AGT	243;245;245	A,C;G;T	242,1;245;245	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	1	SNP	p	S87I	0	.	.	259	261	AGT	836	838	AGT	243;245;245	A,C;G;T	242,1;245;245	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	1	SNP	p	S87W	0	.	.	259	261	AGT	836	838	AGT	243;245;245	A,C;G;T	242,1;245;245	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5156	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3380	190.0	1	SNP	p	S88P	0	.	.	262	264	TCC	839	841	TCC	248;251;254	T;C,G;C	248;250,1;254	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4534	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3244	174.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1953	1955	GGC	260;257;251	G;G;C,A	260;257;250,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1468	1470	GCA	233;235;235	G;C;A	233;235;235	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1471	1473	ATC	237;237;239	A;T;C	237;237;239	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1483	1485	GTG	235;236;233	G;T,G;G,C	235;235,1;232,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1483	1485	GTG	235;236;233	G;T,G;G,C	235;235,1;232,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1987	1989	ACC	246;244;242	A;C,A;C	246;243,1;242	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2041	2043	GCG	219;220;220	G;C;G	219;220;220	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2041	2043	GCG	219;220;220	G;C;G	219;220;220	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2164	2166	GGT	214;214;213	G;G;T,C	214;214;212,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2173	2175	GGC	215;217;216	G;G;C	215;217;215	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4162	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2884	179.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2191	2193	CCG	217;218;219	C,G;C,G;G	216,1;217,1;219	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5922	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3710	198.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2330	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2128	136.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	545	547	GGC	154;153;154	G;G;C	154;153;154	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2330	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2128	136.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	727	727	C	154	C	154	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	575	577	GAA	264;265;266	G;A;A	264;265;266	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	722	724	GCT	240;238;236	G;C,A;T	240;237,1;236	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	728	730	AGC	235;237;234	A;G;C	235;237;234	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	820	821	CG	239;244	C;G	239;244	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	823	825	CAG	242;244;244	C;A;G	242;244;244	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	827	829	AAA	242;243;250	A,C;A,C;A,C,T	241,1;241,1;247,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	890	892	GAA	268;270;271	G,A;A;A,T	265,3;270;270,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	914	916	GCA	293;294;296	G,T;C,T;A	292,1;293,1;296	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1097	1099	GAT	248;247;247	G;A,G;T,G	248;246,1;246,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1100	1102	GGT	246;245;244	G,T;G;T,A	245,1;245;243,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	I218V	NONSYN	652	654	ATA	1115	1117	GTG	239;238;236	G;T;G	239;238;236	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	0	.	p	.	0	D333E	NONSYN	997	999	GAC	1460	1462	GAA	304;304;303	G;A;A	304;304;303	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	1	SNP	p	G120K	1	.	.	358	360	AAG	820	822	CGG	239;244;245	C;G;G,T,C	239;244;243,1,1	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	1	SNP	p	A121D	1	.	.	361	363	GAC	823	826	CGC	242;244;243	C;G;CAAA,CAA	242;244;236,1	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3118	porB1b	1047	1047	98.0	porB1b.l15.c30.ctg.1	1652	227.6	1	SNP	p	D121N	0	.	.	361	363	GAC	823	826	CGC	242;244;243	C;G;CAAA,CAA	242;244;236,1	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10560	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5260	249.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1560	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1565	124.1	1	SNP	p	V57M	1	.	.	169	171	ATG	769	771	ATG	291;288;288	A;T;G	291;288;288	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
